{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:23:51Z","timestamp":1793395431016,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:00:00Z","timestamp":1614816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:00:00Z","timestamp":1614816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Research Grants in the Natural Sciences, The Mitsubishi Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In Coronavirus disease 2019 (COVID-19) subjects, recent evidence suggests the presence of unique coagulation abnormalities. In this study, we performed clot waveform analyses to investigate whether specific modulations are observed in COVID-19 subjects. We analyzed the second derivative of the absorbance in routine APTT tests performed using an ACL-TOP system. We observed high frequencies of abnormal patterns in APTT second-derivative curves that could be classified into an early shoulder type, a late shoulder type, or a biphasic type, high maximum first-derivative and second-derivative peak levels, and a low minimum second-derivative peak level in COVID-19 subjects. These modulations were not observed in subjects with disseminated intravascular coagulation. These abnormal patterns are also observed in patients with lupus anticoagulant, hemophilia, or factor IX deficiency. The plasma fibrinogen levels might also be involved in the abnormal APTT waveforms, especially the high maximum first-derivative and second-derivative peak levels. The abnormal patterns in the APTT second-derivative curves appear with highest frequency at around 2\u00a0weeks after the onset of COVID-19 and were not associated with the severity of COVID-19. These results suggest the possible presence of a specific abnormal coagulopathy in COVID-19.<\/jats:p>","DOI":"10.1038\/s41598-021-84776-8","type":"journal-article","created":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T11:04:29Z","timestamp":1614855869000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Clot waveform of APTT has abnormal patterns in subjects with COVID-19"],"prefix":"10.1038","volume":"11","author":[{"given":"Takuya","family":"Shimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Kurano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Kanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahoko","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koh","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Jubishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohei","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Okugawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoji","family":"Moriya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Yatomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,4]]},"reference":[{"key":"84776_CR1","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/jth.14768","volume":"18","author":"N Tang","year":"2020","unstructured":"Tang, N., Li, D., Wang, X. & Sun, Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J. Thromb. Haemost. 18, 844\u2013847. https:\/\/doi.org\/10.1111\/jth.14768 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"84776_CR2","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen, N. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395, 507\u2013513. https:\/\/doi.org\/10.1016\/S0140-6736(20)30211-7 (2020).","journal-title":"Lancet"},{"key":"84776_CR3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.1585","author":"D Wang","year":"2020","unstructured":"Wang, D. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA https:\/\/doi.org\/10.1001\/jama.2020.1585 (2020).","journal-title":"JAMA"},{"key":"84776_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.thromres.2020.04.024","volume":"191","author":"C Lodigiani","year":"2020","unstructured":"Lodigiani, C. et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan Italy. Thromb. Res. 191, 9\u201314. https:\/\/doi.org\/10.1016\/j.thromres.2020.04.024 (2020).","journal-title":"Thromb. Res."},{"key":"84776_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.05.001","author":"I Paranjpe","year":"2020","unstructured":"Paranjpe, I. et al. Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19. J. Am. Coll. Cardiol. https:\/\/doi.org\/10.1016\/j.jacc.2020.05.001 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"84776_CR6","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/jth.14817","volume":"18","author":"N Tang","year":"2020","unstructured":"Tang, N. et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J. Thromb. Haemost. 18, 1094\u20131099. https:\/\/doi.org\/10.1111\/jth.14817 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"84776_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14830","author":"S Cui","year":"2020","unstructured":"Cui, S., Chen, S., Li, X., Liu, S. & Wang, F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J. Thromb. Haemost. https:\/\/doi.org\/10.1111\/jth.14830 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"84776_CR8","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/jth.14810","volume":"18","author":"J Thachil","year":"2020","unstructured":"Thachil, J. et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J. Thromb. Haemost. 18, 1023\u20131026. https:\/\/doi.org\/10.1111\/jth.14810 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"84776_CR9","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","volume":"395","author":"Z Varga","year":"2020","unstructured":"Varga, Z. et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet 395, 1417\u20131418. https:\/\/doi.org\/10.1016\/S0140-6736(20)30937-5 (2020).","journal-title":"Lancet"},{"key":"84776_CR10","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1093\/infdis\/jiaa528","volume":"222","author":"C Guervilly","year":"2020","unstructured":"Guervilly, C. et al. Circulating endothelial cells as a marker of endothelial injury in severe COVID-19. J. Infect. Dis. 222, 1789\u20131793. https:\/\/doi.org\/10.1093\/infdis\/jiaa528 (2020).","journal-title":"J. Infect. Dis."},{"key":"84776_CR11","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta, P. et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395, 1033\u20131034. https:\/\/doi.org\/10.1016\/S0140-6736(20)30628-0 (2020).","journal-title":"Lancet"},{"key":"84776_CR12","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1111\/jth.15016","volume":"18","author":"C Nougier","year":"2020","unstructured":"Nougier, C. et al. Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis. J. Thromb. Haemost. 18, 2215\u20132219. https:\/\/doi.org\/10.1111\/jth.15016 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"84776_CR13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2013656","author":"L Bowles","year":"2020","unstructured":"Bowles, L. et al. Lupus anticoagulant and abnormal coagulation tests in patients with COVID-19. N. Engl. J. Med. https:\/\/doi.org\/10.1056\/NEJMc2013656 (2020).","journal-title":"N. Engl. J. Med."},{"key":"84776_CR14","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.120.315547","author":"A Rosell","year":"2020","unstructured":"Rosell, A. et al. Patients with COVID-19 have elevated levels of circulating extracellular vesicle tissue factor activity that is associated with severity and mortality. Arterioscler Thromb. Vasc. Biol. https:\/\/doi.org\/10.1161\/ATVBAHA.120.315547 (2020).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"84776_CR15","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.138999","author":"Y Zuo","year":"2020","unstructured":"Zuo, Y. et al. Neutrophil extracellular traps in COVID-19. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.138999 (2020).","journal-title":"JCI Insight"},{"key":"84776_CR16","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13045-020-00954-7","volume":"13","author":"S Zhang","year":"2020","unstructured":"Zhang, S. et al. SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. J. Hematol. Oncol. 13, 120. https:\/\/doi.org\/10.1186\/s13045-020-00954-7 (2020).","journal-title":"J. Hematol. Oncol."},{"key":"84776_CR17","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/ijlh.12724","volume":"39","author":"PO Sevenet","year":"2017","unstructured":"Sevenet, P. O. & Depasse, F. Clot waveform analysis: Where do we stand in 2017?. Int. J. Lab. Hematol. 39, 561\u2013568. https:\/\/doi.org\/10.1111\/ijlh.12724 (2017).","journal-title":"Int. J. Lab. Hematol."},{"key":"84776_CR18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1751-553X.2010.01248.x","volume":"33","author":"C Solano","year":"2011","unstructured":"Solano, C., Zerafa, P. & Bird, R. A study of atypical APTT derivative curves on the ACL TOP coagulation analyser. Int. J. Lab. Hematol. 33, 67\u201378. https:\/\/doi.org\/10.1111\/j.1751-553X.2010.01248.x (2011).","journal-title":"Int. J. Lab. Hematol."},{"key":"84776_CR19","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1097\/MBC.0000000000000436","volume":"27","author":"N Tokunaga","year":"2016","unstructured":"Tokunaga, N. et al. Usefulness of the second-derivative curve of activated partial thromboplastin time on the ACL-TOP coagulation analyzer for detecting factor deficiencies. Blood Coagul. Fibrinol. 27, 474\u2013476. https:\/\/doi.org\/10.1097\/MBC.0000000000000436 (2016).","journal-title":"Blood Coagul. Fibrinol."},{"key":"84776_CR20","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1177\/1076029617724230","volume":"24","author":"T Matsumoto","year":"2018","unstructured":"Matsumoto, T. et al. An evaluation of the activated partial thromboplastin time waveform. Clin. Appl. Thromb. Hemost. 24, 764\u2013770. https:\/\/doi.org\/10.1177\/1076029617724230 (2018).","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"84776_CR21","doi-asserted-by":"publisher","first-page":"e0157835","DOI":"10.1371\/journal.pone.0157835","volume":"11","author":"T Tokutake","year":"2016","unstructured":"Tokutake, T. et al. Exogenous magnesium chloride reduces the activated partial thromboplastin times of lupus anticoagulant-positive patients. PLoS ONE 11, e0157835. https:\/\/doi.org\/10.1371\/journal.pone.0157835 (2016).","journal-title":"PLoS ONE"},{"key":"84776_CR22","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1046\/j.1365-2257.2002.00457.x","volume":"24","author":"CH Toh","year":"2002","unstructured":"Toh, C. H. & Giles, A. R. Waveform analysis of clotting test optical profiles in the diagnosis and management of disseminated intravascular coagulation (DIC). Clin. Lab. Haematol. 24, 321\u2013327. https:\/\/doi.org\/10.1046\/j.1365-2257.2002.00457.x (2002).","journal-title":"Clin. Lab. Haematol."},{"key":"84776_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12959-019-0201-0","volume":"17","author":"K Suzuki","year":"2019","unstructured":"Suzuki, K. et al. Usefulness of the APTT waveform for the diagnosis of DIC and prediction of the outcome or bleeding risk. Thromb. J. 17, 12. https:\/\/doi.org\/10.1186\/s12959-019-0201-0 (2019).","journal-title":"Thromb. J."},{"key":"84776_CR24","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1160\/TH13-09-0800","volume":"111","author":"V Huck","year":"2014","unstructured":"Huck, V., Schneider, M. F., Gorzelanny, C. & Schneider, S. W. The various states of von Willebrand factor and their function in physiology and pathophysiology. Thromb. Haemost. 111, 598\u2013609. https:\/\/doi.org\/10.1160\/TH13-09-0800 (2014).","journal-title":"Thromb. Haemost."},{"key":"84776_CR25","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1182\/blood.V87.6.2292.bloodjournal8762292","volume":"87","author":"SJ Koppelman","year":"1996","unstructured":"Koppelman, S. J. et al. Requirements of von Willebrand factor to protect factor VIII from inactivation by activated protein C. Blood 87, 2292\u20132300 (1996).","journal-title":"Blood"},{"key":"84776_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14850","author":"M Panigada","year":"2020","unstructured":"Panigada, M. et al. Hypercoagulability of COVID-19 patients in intensive care unit. A report of thromboelastography findings and other parameters of hemostasis. J. Thromb. Haemost. https:\/\/doi.org\/10.1111\/jth.14850 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"84776_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-020-02318-x","author":"BE Fan","year":"2020","unstructured":"Fan, B. E. et al. COVID-19 associated coagulopathy in critically ill patients: a hypercoagulable state demonstrated by parameters of haemostasis and clot waveform analysis. J. Thromb. Thrombol. https:\/\/doi.org\/10.1007\/s11239-020-02318-x (2020).","journal-title":"J. Thromb. Thrombol."},{"key":"84776_CR28","doi-asserted-by":"publisher","DOI":"10.1097\/MBC.0000000000000998","author":"R De Cristofaro","year":"2021","unstructured":"De Cristofaro, R. et al. Marked von Willebrand factor and factor VIII elevations in severe acute respiratory syndrome coronavirus-2-positive, but not severe acute respiratory syndrome coronavirus-2-negative, pneumonia: a case-control study. Blood Coagul. Fibrinol. https:\/\/doi.org\/10.1097\/MBC.0000000000000998 (2021).","journal-title":"Blood Coagul. Fibrinol."},{"key":"84776_CR29","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.thromres.2020.10.025","volume":"197","author":"M Hardy","year":"2021","unstructured":"Hardy, M. et al. Prothrombotic disturbances of hemostasis of patients with severe COVID-19: a prospective longitudinal observational study. Thromb. Res. 197, 20\u201323. https:\/\/doi.org\/10.1016\/j.thromres.2020.10.025 (2021).","journal-title":"Thromb. Res."},{"key":"84776_CR30","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1002\/ajh.25829","volume":"95","author":"E Terpos","year":"2020","unstructured":"Terpos, E. et al. Hematological findings and complications of COVID-19. Am. J. Hematol. 95, 834\u2013847. https:\/\/doi.org\/10.1002\/ajh.25829 (2020).","journal-title":"Am. J. Hematol."},{"key":"84776_CR31","doi-asserted-by":"publisher","first-page":"9126148","DOI":"10.1155\/2020\/9126148","volume":"2020","author":"E Kampouri","year":"2020","unstructured":"Kampouri, E. et al. Predicting venous thromboembolic events in patients with coronavirus disease 2019 requiring hospitalization: an observational retrospective study by the COVIDIC Initiative in a Swiss University Hospital. Biomed. Res. Int. 2020, 9126148. https:\/\/doi.org\/10.1155\/2020\/9126148 (2020).","journal-title":"Biomed. Res. Int."},{"key":"84776_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/v11010073","author":"B Yan","year":"2019","unstructured":"Yan, B. et al. Characterization of the lipidomic profile of human coronavirus-infected cells: implications for lipid metabolism remodeling upon coronavirus replication. Viruses https:\/\/doi.org\/10.3390\/v11010073 (2019).","journal-title":"Viruses"},{"key":"84776_CR33","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1038\/s41598-021-81166-y","volume":"11","author":"CW Tan","year":"2021","unstructured":"Tan, C. W. et al. Clinical and laboratory features of hypercoagulability in COVID-19 and other respiratory viral infections amongst predominantly younger adults with few comorbidities. Sci. Rep. 11, 1793. https:\/\/doi.org\/10.1038\/s41598-021-81166-y (2021).","journal-title":"Sci. Rep."},{"key":"84776_CR34","doi-asserted-by":"publisher","first-page":"E156","DOI":"10.1002\/ajh.25822","volume":"95","author":"CW Tan","year":"2020","unstructured":"Tan, C. W. et al. Critically ill COVID-19 infected patients exhibit increased clot waveform analysis parameters consistent with hypercoagulability. Am. J. Hematol. 95, E156\u2013E158. https:\/\/doi.org\/10.1002\/ajh.25822 (2020).","journal-title":"Am. J. Hematol."},{"key":"84776_CR35","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12959-020-00230-1","volume":"18","author":"M Hardy","year":"2020","unstructured":"Hardy, M. et al. Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory. Thromb. J. 18, 17. https:\/\/doi.org\/10.1186\/s12959-020-00230-1 (2020).","journal-title":"Thromb. J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-84776-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-84776-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-84776-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T04:53:39Z","timestamp":1670043219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-84776-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,4]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["84776"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-84776-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,4]]},"assertion":[{"value":"11 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5190"}}